Consern Pharma

Ludhiana, India Founded: 1996 • Age: 30 yrs
Pharmaceutical manufacturing and research in Neuro-Psychiatry and other healthcare segments.

About Consern Pharma

Consern Pharma is a Healthcare company based in Ludhiana (India) founded in 1996. Pharmaceutical manufacturing and research in Neuro-Psychiatry and other healthcare segments. The company has 504 employees. Its Indian entity Consern Pharma Limited reported revenue of β‚Ή100 Cr. Consern Pharma offers products and services including CNS Formulations and Diabetic Medications. Its focus areas include Pharmaceuticals, Neuro-Psychiatry, CNS Formulations and Diabetic Care.

Company details

Consern Pharma is recognized for its 28-year legacy in pharmaceutical manufacturing, research, and formulation development, particularly in the Neuro-Psychiatry segment, where reliable quality is maintained. It is based in Ludhiana, India, and has expanded to 26 states and 9 countries, serving over 8,950 doctors and reaching 14,372 pharmacies with more than 766 medicines. A commitment to quality and innovation is demonstrated through partnerships with 298 distributors, aiding in the treatment of over 32 million patients globally, while WHO-GMP certification ensures standards are met in healthcare solutions.

  • Headquarters Ludhiana, India
  • Employees 504
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website consernpharma.com
  • Social LinkedIn X Facebook Instagram
  • Legal Name Consern Pharma Limited
  • Date of Incorporation 17 Oct, 2001
  • Jurisdiction Ludhiana, Punjab, India
Operational Areas
Key Metrics
  • Annual Revenue
    ₹100 Cr

    FY 2025 · -2% YoY

  • Net Profit
    ₹9.64 Cr

    FY 2025 · 10% margin

  • EBITDA
    ₹15.10 Cr

    FY 2025 · 15% margin

  • Employee Count
    504

Products & Services of Consern Pharma

Consern Pharma offers a comprehensive portfolio of products and services, including CNS Formulations and Diabetic Medications.

CNS Formulations
Pharmaceuticals

CNS formulations are manufactured for the Neuro-Psychiatry segment, where stable and reliable medications are provided to address neurological conditions.

Diabetic Medications
Pharmaceuticals

Diabetic medications are developed for the diabetic segment, ensuring quality healthcare solutions are delivered through formulations that support patient treatment.

Board of directors of Consern Pharma Limited (Consern Pharma)

Consern Pharma Limited is the primary company behind Consern Pharma. The board of Consern Pharma Limited currently have 5 directors; the longest-serving is Seema Mahajan, appointed in 2001. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Seema Mahajan
DIN 00605605
Whole-time director17 Oct 200125 yrsConsern Pharma Limited
Kuljive Mahajan
DIN 00603252
Managing Director01 Apr 200422 yrs 7 moConsern Pharma Limited
Atul Bhatara
DIN 08847114
Director01 Oct 20242 yrs 1 moConsern Pharma Limited
Riaz K Mahajan
DIN 11085295
Additional Director01 Jun 20251 yr 5 moConsern Pharma Limited
Suresh Goel
DIN 00478373
Additional Director01 Sep 20251 yr 2 moConsern Pharma Limited

People of Consern Pharma

12 people are tracked at Consern Pharma (2 in leadership, 10 in team); the tracked headcount is 504.

NameRoleGroup
CEOLeadership
DirectorLeadership
Rajesh Saini
Sales ManagerTeam
Naveen Sharma
Medical RepresentativeTeam
Akash Sharma
Senior ExecutiveTeam
Anoop Kumar Moriya
Senior ExecutiveTeam
Consern Pharma Limited
BusinessTeam
Sunny Dogra
ExecutiveTeam
Sandeep Panday
QA ExecutiveTeam
Manpreet Singh
Marketing ManagerTeam
Dherrendra Pratap Singh
Senior Area Sales ManagerTeam
Dhiraj Kumar
RSMTeam
Premium access

Complete people profiles for Consern Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Consern Pharma

Figures of Consern Pharma Limited, the primary company behind Consern Pharma, for FY 2025. Revenue was ₹100 Cr (-2% year on year). Net profit was ₹9.64 Cr (10% margin). EBITDA was ₹15.10 Cr (15% margin). Revenue has grown at a compounded annual rate of +19% over three years and +17% over five years.

  • ₹100 CrRevenue · FY 2025 · -2% YoY
  • ₹9.64 CrNet profit · 10% margin
  • ₹15.10 CrEBITDA · 15% margin
  • ₹30.8 LakhPaid-up capital
  • 504Employees (provident fund records)
  • +19%Revenue CAGR, 3 years
  • +17%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Consern Pharma Limited are on its company page.

Premium access

Detailed financial statements for Consern Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of Consern Pharma

The website of Consern Pharma (consernpharma.com) receives about 3.2K visits a month.

  • Monthly visits
    3.2K

    ▼ 63% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Consern Pharma

Consern Pharma was founded in 1996.

Consern Pharma is headquartered in Ludhiana, India. It is registered at Ludhiana, Punjab, India.

Consern Pharma has 504 employees.

The primary company behind Consern Pharma, Consern Pharma Limited, reported revenue of β‚Ή100 Cr for FY 2025, down 2% year on year.

Consern Pharma is recognized for its 28-year legacy in pharmaceutical manufacturing, research, and formulation development, particularly in the Neuro-Psychiatry segment, where reliable quality is maintained. It is based in Ludhiana, India, and has expanded to 26 states and 9 countries, serving over 8,950 doctors and reaching 14,372 pharmacies with more than 766 medicines. A commitment to quality and innovation is demonstrated through partnerships with 298 distributors, aiding in the treatment of over 32 million patients globally, while WHO-GMP certification ensures standards are met in healthcare solutions.

Consern Pharma offers CNS Formulations and Diabetic Medications.

Consern Pharma operates through Consern Pharma Limited.

The legal entities of Consern Pharma currently have 5 directors, including Seema Mahajan, Kuljive Mahajan, Riaz K Mahajan and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available